Florida Senate - 2023                        COMMITTEE AMENDMENT
       Bill No. SB 254
       
       
       
       
       
       
                                Ì302480}Î302480                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                   Comm: OO            .                                
                  03/13/2023           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Book) recommended the following:
       
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete lines 281 - 297
    4  and insert:
    5  the pharmaceutical product or perform the procedure has:
    6         (a) Informed the patient of the nature and risks of the
    7  prescription or procedure in order for the patient to make a
    8  prudent decision;
    9         (b) Provided the informed consent form, as approved by the
   10  department, to the patient; and
   11         (c) Received the patient’s written acknowledgment, before
   12  the prescription or procedure is prescribed, administered, or
   13  performed, that the information required to be provided under
   14  this subsection has been provided.
   15  
   16  ================= T I T L E  A M E N D M E N T ================
   17  And the title is amended as follows:
   18         Delete lines 50 - 52
   19  and insert:
   20         applicability;